Contrast-enhanced ultrasonography using cadence-contrast pulse sequencing technology for targeted biopsy of the prostate

BJU International

Volumn 103, Issue 4, 2009, Pages 458-463

  Aigner, Friedrich ^a   Pallwein, Leo ^a   Mitterberger, Michael ^a   Pinggera, Germar M ^a   Mikuz, Gregor ^b   Horninger, Wolfgang ^a   Frauscher, Ferdinand ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b MEDICAL UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Biopsy; Contrast agent; Detection; Pathological analysis; Prostate cancer; Ultrasonography

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; SONOVUE;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FALSE POSITIVE RESULT; GLEASON SCORE; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; REPEATED DRUG DOSE;

ADULT; AGED; BIOPSY, NEEDLE; CONTRAST MEDIA; HUMANS; MALE; MICROCIRCULATION; MIDDLE AGED; PROSTATE; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 59249098811     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.08038.x     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2008. CA Cancer J Clin 2008 58 : 71 96
2. Aus G, Abbou CC, Bolla M et al. European Association of Urology. EAU guidelines on prostate cancer. Eur Urol 2005 48 : 546 51
3. Scardino PT, Weaver R, Hudson MA. Early detection of prostate cancer. Hum Pathol 1992 23 : 211 22
4. Rifkin MD. Ultrasound of the Prostate, 3rd edn. Philadelphia : Lippincott-Raven, 1997
5. Schröder FH, Carter HB, Wolters T et al. Early detection of prostate cancer in 2007. Part 1. PSA and PSA kinetics. Eur Urol 2008 53 : 468 77
6. Gómez Veiga F, Ponce Reixa J, Barbagelata López A, Fernández Rosado E, Gonzaåez Martiñ M. Current role of PSA and other markers in the diagnosis of prostate cancer. Arch Esp Urol 2006 59 : 1069 82
7. Dahnert WF, Hamper UM, Eggleston JC, Walsh PC, Sanders RC. Prostatic evaluation by transrectal sonography with histopathologic correlation: the echopenic appearance of early carcinoma. Radiology 1986 158 : 97 102
8. Chang JJ, Shinohara K, Bhargava V, Presti JC. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 1998 160 : 2111 4
9. Salo JO, Rannikko S, Makinen J, Lehtonen T. Echogenic structure of prostatic cancer imaged on radical prostatectomy specimens. Prostate 1987 10 : 1 9
10. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989 142 : 71 4
11. Norberg M, Egevad L, Holmberg L et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 1997 50 : 562 6
12. Cookson MS. Update on transrectal ultrasound-guided needle biopsy of the prostate. Mol Urol 2000 4 : 93 7
13. Eskew LA, Bare RL, McCullough DL. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 1997 157 : 199 202
14. Naughton CK, Miller DC, Mager DE, Ornstein DK, Catalona WJ. A prospective randomized trial comparing 6 versus 12 prostate biopsy cores. impact on cancer detection. J Urol 2000 164 : 388 92
15. Simon J, Kuefer R, Bartsch G Volkmer BG, Hautmann RE, Gottfried HW. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction. BJU Int 2008 March 5 Epub ahead of print
16. Jones JS, Patel A, Schoenfield L, Rabets JC, Zippe CD, Magi-Galluzzi C. Saturation technique does not improve cancer detection as an initial prostate biopsy strategy. J Urol 2006 175 : 485 8
17. Loch T. Urologic imaging for localized prostate cancer in 2007. World J Urol 2007 25 : 121 9
18. Engelbrecht MR, Jager GJ, Laheij RJ, Verbeek AL, van Lier HJ, Barentsz JO. Local staging of prostate cancer using magnetic resonance imaging: a meta-analysis. Eur Radiol 2002 12 : 2294 302
19. Frauscher F, Klauser A, Berger AP et al. The value of ultrasound (US) in the diagnosis of prostate cancer. Radiologe 2003 43 : 455 63
20. Linden RA, Trabulsi EJ, Forsberg F, Gittens PR, Gomella LG, Halpern EJ. Contrast enhanced ultrasound flash replenishment method for directed prostate biopsies. J Urol 2007 178 : 2354 8
21. Salomon G, Köllerman J, Thederan I et al. Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy. Eur Urol 2008 March 10 Epub ahead of print
22. van Moorselaar RJ, Voest EE. Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches. Mol Cell Endocrinol 2002 197 : 239 50
23. Goldberg BB, Liu JB, Forsberg F. Ultrasound contrast agents: a review. Ultrasound Med Biol 1994 20 : 319 33
24. Forsberg F, Merton DA, Liu JB et al. Clinical applications of ultrasound contrast agents. Ultrasonics 1998 36 : 695 701
25. Frauscher F, Pallwein L, Klauser A et al. Ultrasound contrast agents and prostate cancer. Radiologe 2005 45 : 544 51
26. von Herbay A, Schick D, Horger M, Gregor M. Low-MI-sonography with the contrast-agent SonoVue in the diagnosis of infarction of the spleen, kidney, liver and pancreas. Ultraschall Med 2006 27 : 445 50
27. Bartels E, Henning S, Wellmer A, Giraldo-Velasquez M, Kermer P. Evaluation of cerebral perfusion deficit in stroke patients using new transcranial contrast imaging CPS technology - preliminary results. Ultraschall Med 2005 26 : 478 86
28. Bleuzen A, Tranquart F. Incidental liver lesions. diagnostic value of cadence contrast pulse sequencing (CPS) and SonoVue. Eur Radiol 2004 14 (Suppl. 8 53 62
29. Wink MH, Laguna MP, Lagerveld BW, de la Rosette JJ, Wijkstra H. Contrast-enhanced ultrasonography in the follow-up of cryoablation of renal tumours: a feasibility study. BJU Int 2007 99 : 1371 5
30. Giannoni MF, Fanelli F, Citone M et al. Contrast ultrasound imaging: the best method to detect type 2 endoleak during endovascular aneurysm repair follow-up. Interact Cardiovasc Thorac Surg 2007 6 : 359 62
31. Pelzer AE, Bektic J, Berger AP et al. Are transition zone biopsies still necessary to improve prostate cancer detection? Results from the Tyrol screening project. Eur Urol 2005 48 : 916 21
32. Heijmink SW, van Moerkerk H, Kiemeney LA, Witjes JA, Frauscher F, Barentsz JO. A comparison of the diagnostic performance of systematic versus ultrasound-guided biopsies of prostate cancer. Eur Radiol 2006 16 : 927 38
33. Motulsky H. Intuitive Biostatistics. New York : Oxford University Press, 1995 : 129
34. Borre M, Offersen BV, Nerstrøm B, Overgaard J. Microvessel density predicts survival in prostate cancer patients subjected to watchful waiting. Br J Cancer 1998 78 : 940 4
35. Bostwick DG, Wheeler TM, Blute M et al. Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies. Urology 1996 48 : 47 57
36. Newman JS, Bree RL, Rubin JM. Prostate cancer. diagnosis with color Doppler sonography with histologic correlation of each biopsy site. Radiology 1995 195 : 86 90
37. Roy C, Buy X, Lang H, Saussine C, Jacqmin DL. Contrast enhanced color Doppler endorectal sonograph of the prostate: efficiency for detecting peripheral zone tumors and role for biopsy procedure. J Urol 2003 170 : 69 72
38. Guichard G, Larré S, Gallina A et al. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients. Eur Urol 2007 52 : 430 5
39. Mitterberger M, Pinggera GM, Horninger W et al. Comparison of contrast enhanced color Doppler targeted biopsy to conventional systematic biopsy: impact on Gleason score. J Urol 2007 178 : 464 8